Nebulized 5% Hypertonic Saline for the Treatment of Bronchiolitis
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The investigators reasoned that a hypertonic saline concentration higher than 3% could be
safe and more efficacious in the treatment of bronchiolitis, alleviating severe symptoms and
preventing the need for hospitalization in some instances.